Renaissance Technologies (RenTech)'s DSGN Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 408,200 shares of Design Therapeutics, Inc. (DSGN) worth $4.34 M, representing 0.01% of the portfolio. First purchased in 2023-Q1, this medium-term investment has been held for 13 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in DSGN, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2023, adding 484,600 shares. Largest reduction occurred in Q1 2024, reducing 195,400 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s Design Therapeutics (DSGN) Holding Value Over Time
Track share changes against reported price movement
Quarterly Design Therapeutics (DSGN) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +121,100 | Add 42.18% | 408,200 | $10.64 |
| Q4 2025 | +12,800 | Add 4.67% | 287,100 | $9.38 |
| Q3 2025 | +6,500 | Add 2.43% | 274,300 | $7.53 |
| Q2 2025 | +2,800 | Add 1.06% | 267,800 | $3.37 |
| Q1 2025 | +11,500 | Add 4.54% | 265,000 | $3.86 |
| Q4 2024 | -20,500 | Reduce 7.48% | 253,500 | $6.17 |
| Q3 2024 | -110,075 | Reduce 28.66% | 274,000 | $5.38 |
| Q2 2024 | -69,325 | Reduce 15.29% | 384,075 | $3.35 |
| Q1 2024 | -195,400 | Reduce 30.12% | 453,400 | $4.03 |
| Q4 2023 | +484,600 | Add 295.13% | 648,800 | $2.65 |
| Q3 2023 | +69,092 | Add 72.65% | 164,200 | $2.36 |
| Q2 2023 | -6,643 | Reduce 6.53% | 95,108 | $0.01 |
| Q1 2023 | +101,751 | New Buy | 101,751 | $0.01 |
Renaissance Technologies (RenTech)'s Design Therapeutics Investment FAQs
Renaissance Technologies (RenTech) first purchased Design Therapeutics, Inc. (DSGN) in Q1 2023, acquiring 101,751 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held Design Therapeutics, Inc. (DSGN) for 13 quarters since Q1 2023.
Renaissance Technologies (RenTech)'s largest addition to Design Therapeutics, Inc. (DSGN) was in Q4 2023, adding 648,800 shares worth $1.72 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 408,200 shares of Design Therapeutics, Inc. (DSGN), valued at approximately $4.34 M.
As of the Q1 2026 filing, Design Therapeutics, Inc. (DSGN) represents approximately 0.01% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in Design Therapeutics, Inc. (DSGN) was 648,800 shares, as reported at the end of Q4 2023.